Sugi Predict

Sugi Predict / Compounds / SCHEMBL7324398

SCHEMBL7324398

SCHEMBL7324398

CCOC(=O)CNC1CCCC1

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.54
▸ POLB P06746 1/20 0.54
▸ L3MBTL1 Q9Y468 2/20 0.47
▸ THRB P10828 1/20 0.47
▸ ATM Q13315 1/20 0.47
▸ ALDH1A1 P00352 2/20 0.47
▸ GAA P10253 3/20 0.46
▸ MGAM O43451 1/20 0.46
▸ SI P14410 1/20 0.46
▸ MGAM2 Q2M2H8 1/20 0.46
▸ KMT2A Q03164 1/20 0.42
▸ EPHX2 P34913 2/20 0.42
▸ HTT P42858 1/20 0.41
▸ HPGD P15428 2/20 0.40
▸ SMYD3 Q9H7B4 1/20 0.40
▸ TSHR P16473 1/20 0.39
▸ TP53 P04637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1320792 0.98 KDM4E (0.56) KDM4EPOLBL3MBTL1THRBATM
Hydrochloric Acid SCHEMBL4274616 0.98 KDM4E (0.52) KDM4EPOLBL3MBTL1THRBATM
SCHEMBL7327410 0.98 KDM4E (0.56) KDM4EPOLBL3MBTL1THRBATM
SCHEMBL7326792 0.98 KDM4E (0.56) KDM4EPOLBL3MBTL1THRBATM
Hydrochloric Acid SCHEMBL3742446 0.96 KDM4E (0.55) KDM4EPOLBL3MBTL1THRBATM
Hydrochloric Acid SCHEMBL7333958 0.96 KDM4E (0.55) KDM4EPOLBL3MBTL1THRBATM
Hydrochloric Acid SCHEMBL7331359 0.96 KDM4E (0.55) KDM4EPOLBL3MBTL1THRBATM
SCHEMBL11119817 0.96 KDM4E (0.50) KDM4EPOLBL3MBTL1THRBATM
Hydrochloric Acid SCHEMBL11119814 0.94 KDM4E (0.49) KDM4EPOLBL3MBTL1THRBATM
SCHEMBL493716 0.92 GAA (0.50) KDM4EPOLBL3MBTL1THRBATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230065740-A1 CYCLIN-DEPENDENT KINASE INHIBITORS SPV THERAPEUTICS INC. 2023-03-02 — — US disclosed
CN-108586356-B Ribociclib new intermediate and synthetic method for preparing Ribociclib by using same 杭州科巢生物科技有限公司 2021-02-19 — — CN disclosed
US-10723739-B2 Processes for the preparation of Ribociclib and intermediates thereof APOTEX INC. (CA) 2020-07-28 — — US disclosed
WO-2020140054-A1 CYCLIN-DEPENDENT KINASE INHIBITORS SPV THERAPEUTICS INC. (US) 2020-07-02 — — WO disclosed
US-20190345163-A1 Processes for the Preparation of Ribociclib and Intermediates Thereof THE BANK OF NOVA SCOTIA (CA) 2019-11-14 — — US disclosed
US-8962843-B2 1,3,4-oxadiazole and 1,3,4-thiadiazole beta-lactamase inhibitors CUBIST PHARMACEUTICALS, INC. (US) 2015-02-24 — — US disclosed
US-8962844-B2 1,3,4-oxadiazole and 1,3,4-thiadiazole β-lactamase inhibitors CUBIST PHARMACEUTICALS, INC. (US) 2015-02-24 — — US disclosed
US-20150031659-A1 1,3,4-OXADIAZOLE AND 1,3,4-THIADIAZOLE BETA-LACTAMASE INHIBITORS MERCK SHARP & DOHME CORP. 2015-01-29 — — US disclosed
US-20150031665-A1 1,3,4-OXADIAZOLE AND 1,3,4-THIADIAZOLE BETA-LACTAMASE INHIBITORS MERCK SHARP & DOHME CORP. 2015-01-29 — — US disclosed
US-8940897-B2 1,3,4-oxadiazole and 1,3,4-thiadiazole β-lactamase inhibitors CUBIST PHARMACEUTICALS, INC. (US) 2015-01-27 — — US disclosed
US-5559232-A ANTICOAGULANTS HOFFMANN-LA ROCHE INC. (US) 1996-09-24 — — US disclosed
CN-1107839-A Carbox amide HOFFMANN LA ROCHE (CH) 1995-09-06 — — CN disclosed
EP-0640594-A1 Hydantoin derivative as metalloprotease inhibitor FUJIREBIO INC. (JP) 1995-03-01 — — EP disclosed
US-5221665-A N-substituted amides BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 1993-06-22 — — US disclosed
EP-0369391-A2 N-substituted amides BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) 1990-05-23 — — EP disclosed
EP-0092942-B1 PEPTIDE DERIVATIVES, THEIR PRODUCTION AND USE Takeda Chemical Industries, Ltd. (JP) 1987-09-09 — — EP disclosed
US-4472383-A HYPOTENSIVE AGENTS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1984-09-18 — — US disclosed
EP-0057998-B1 ALICYCLIC COMPOUNDS, THEIR PRODUCTION AND USE Takeda Chemical Industries, Ltd. (JP) 1984-08-08 — — EP disclosed
EP-0092942-A2 Peptide derivatives, their production and use Takeda Chemical Industries, Ltd. (JP) 1983-11-02 — — EP disclosed
EP-0057998-A1 Alicyclic compounds, their production and use Takeda Chemical Industries, Ltd. (JP) 1982-08-18 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150031665-A1 1,3,4-OXADIAZOLE AND 1,3,4-THIADIAZOLE BETA-LACTAMASE INHIBITORS BTD, BLVRB, PEPD KDM4E 2796/4885POLB 793/4885L3MBTL1 699/4885
US-20150031659-A1 1,3,4-OXADIAZOLE AND 1,3,4-THIADIAZOLE BETA-LACTAMASE INHIBITORS BTD, BLVRB, BBOX1 KDM4E 2965/4885POLB 871/4885L3MBTL1 822/4885
US-20230065740-A1 CYCLIN-DEPENDENT KINASE INHIBITORS CDK2, CDK1, CCNK KDM4E 1234/4885POLB 679/4885L3MBTL1 3154/4885
US-10723739-B2 Processes for the preparation of Ribociclib and intermediates thereof RRM2B, RPIA, RTCB KDM4E 1561/4885POLB 38/4885L3MBTL1 3536/4885
US-20190345163-A1 Processes for the Preparation of Ribociclib and Intermediates Thereof RRM2B, RPIA, RTCB KDM4E 1561/4885POLB 38/4885L3MBTL1 3536/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback